Literature DB >> 7946943

Colchicine concentration in leukocytes of patients with familial Mediterranean fever.

O Chappey1, E Niel, M Dervichian, J L Wautier, J M Scherrmann, D Cattan.   

Abstract

Free and total plasma, granulocyte and mononuclear cell colchicine concentrations were measured by radioimmunoassay in 30 patients with familial Mediterranean fever treated with colchicine 0.5 to 2 mg day-1. Colchicine concentrations showed a large intersubject variability in plasma (0.13-1.75 ng ml-1), granulocytes (4 to 64 ng/10(9) cells), and mononuclear cells (11.4 to 57.6 ng/10(9) cells). Whereas unbound and total plasma colchicine concentrations were well correlated, no correlation was found between total or free plasma and granulocyte or mononuclear cell colchicine concentrations and dose of administered colchicine. In contrast, total or free plasma and granulocyte or mononuclear cell colchicine concentrations were correlated using a hyperbolic function indicating saturable colchicine distribution in both leukocyte populations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946943      PMCID: PMC1364844          DOI: 10.1111/j.1365-2125.1994.tb04328.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

Review 1.  Pharmacokinetics of colchicine: a review of experimental and clinical data.

Authors:  A Sabouraud; M Rochdi; M Urtizberea; M O Christen; G Achtert; J M Scherrmann
Journal:  Z Gastroenterol       Date:  1992-03       Impact factor: 2.000

2.  Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.

Authors:  C A Dinarello; M J Chusid; A S Fauci; J I Gallin; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1976 May-Jun

3.  Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.

Authors:  E Z Katz; M Ehrenfeld; M Levy; M Eliakim
Journal:  Arthritis Rheum       Date:  1982-02

4.  Colchicine disposition in human leukocytes after single and multiple oral administration.

Authors:  O N Chappey; E Niel; J L Wautier; P P Hung; M Dervichian; D Cattan; J M Scherrmann
Journal:  Clin Pharmacol Ther       Date:  1993-10       Impact factor: 6.875

5.  Colchicine kinetics in patients with familial Mediterranean fever.

Authors:  H Halkin; S Dany; M Greenwald; Y Shnaps; M Tirosh
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

6.  Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever).

Authors:  M Bar-Eli; M Ehrenfeld; M Levy; R Gallily; M Eliakim
Journal:  Am J Med Sci       Date:  1981 Jan-Feb       Impact factor: 2.378

  6 in total
  3 in total

Review 1.  Colchicine: old and new.

Authors:  Anastasia Slobodnick; Binita Shah; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

2.  Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial.

Authors:  Adem Polat; Cengizhan Acikel; Betul Sozeri; Ismail Dursun; Ozgur Kasapcopur; Nesrin Gulez; Dogan Simsek; Mehmet Saldir; Ipek Dokurel; Hakan Poyrazoglu; Sevcan Bakkaloglu; Ali Delibas; Zelal Ekinci; Nuray A Ayaz; Yasar Kandur; Harun Peru; Yasemin G Kurt; Safiye R Polat; Erbil Unsal; Balahan Makay; Faysal Gok; Seza Ozen; Erkan Demirkaya
Journal:  Arthritis Res Ther       Date:  2016-04-07       Impact factor: 5.156

3.  A Hypothesis Regarding Neurosecretory Inhibition of Stress Mediators by Colchicine in Preventing Stress-Induced Familial Mediterranean Fever Attacks.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; Güven Barıs Cansu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.